Literature DB >> 8932427

A comparison of electroneuronography with facial nerve latency testing for prognostic accuracy in patients with Bell's palsy.

V Danielides1, A Skevas, P Van Cauwenberge.   

Abstract

The purpose of this study was to evaluate the ability of electroneuronography (ENOG), also called evoked electromyography (EEMG), and facial nerve latency testing (FNLT) to assess the prognosis of facial nerve palsy, using the House-Brackmann facial nerve grading system as criterion. From 1988 to 1994 these tests were employed at the ORL Clinic of the University of Ioannina in 250 patients with idiopathic facial nerve palsy. The ENOG test results indicated that when the amplitude of the compound muscle action potentials ranged from 51% to 95% of the normal value, 97% of the patients achieved complete functional recovery (grade I) within at least 2 months. When the muscle action potential decreased to a value below 51% of normal values, prognosis for recovery was considerably worse. FNLT test results indicated that as the latency time extended, the recovery grade of the facial nerve worsened. When latency time was within the normal range (group A patients), about 92% of patients had complete functional recovery. In contrast all patients having either a very extended latency time or unable to be monitored (groups C and D) demonstrated incomplete functional recoveries that ranged from grade II to grade VI. Comparing each test with the House-Brackmann facial nerve grading system, we ascertained that the percent accuracy for ENOG was 97.6%, and that for FNLT was 94.4%.

Entities:  

Mesh:

Year:  1996        PMID: 8932427     DOI: 10.1007/bf00176700

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  14 in total

1.  ELECTRODIAGNOSIS IN FACIAL PALSY.

Authors:  D TAVERNER
Journal:  Arch Otolaryngol       Date:  1965-05

2.  NERVE EXCITABILITY TESTS IN FACIAL PARALYSIS.

Authors:  E P LAUMANS
Journal:  Arch Otolaryngol       Date:  1965-05

3.  Value of nerve-excitability measurements in prognosis of facial palsy.

Authors:  E D CAMPBELL; R P HICKEY; K H NIXON; A T RICHARDSON
Journal:  Br Med J       Date:  1962-07-07

4.  Electrical changes following section of the facial nerve.

Authors:  R W GILLIATT; J C TAYLOR
Journal:  Proc R Soc Med       Date:  1959-12

5.  The role of the facial nerve latency test in the prognosis of Bell's palsy.

Authors:  A T Skevas; V G Danielides; D A Assimakopoulos
Journal:  Laryngoscope       Date:  1990-10       Impact factor: 3.325

6.  Maximal nerve excitability testing versus neuromyography: prognostic value in patients with facial paralysis.

Authors:  K K Adour; M I Sheldon; Z M Kahn
Journal:  Laryngoscope       Date:  1980-09       Impact factor: 3.325

7.  Nerve conduction time in Bell's palsy.

Authors:  R L Rogers
Journal:  Laryngoscope       Date:  1978-02       Impact factor: 3.325

8.  [Comparison of the prognostic value between the nerve excitability test and maximum stimulation test in evaluation of Bell's palsy].

Authors:  V Danielides; A Skevas; I Kastanioundakis; D Anastasopoulos
Journal:  HNO       Date:  1993-09       Impact factor: 1.284

9.  Acute Bell's palsy: prognostic value of evoked electromyography, maximal stimulation, and other electrical tests.

Authors:  M May; F Blumenthal; S R Klein
Journal:  Am J Otol       Date:  1983-07

10.  Early diagnosis in Bell's palsy. A nerve conduction study.

Authors:  H Z Joachims; V Bialik; I Eliachar
Journal:  Laryngoscope       Date:  1980-10       Impact factor: 3.325

View more
  2 in total

1.  Paediatric facial paralysis. Current opinion in evaluation and management.

Authors:  A K Bhattacharyya; S Ghosh
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  1999-07

2.  Correlations between the clinical, histological and neurophysiological examinations in patients before and after parotid gland tumor surgery: verification of facial nerve transmission.

Authors:  Agnieszka Wiertel-Krawczuk; Juliusz Huber; Magdalena Wojtysiak; Wojciech Golusiński; Piotr Pieńkowski; Paweł Golusiński
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-17       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.